SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kosan BioSciences -- KOSN
An SI Board Since May 2001
Posts SubjectMarks Bans Symbol
933 40 0 KOSN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
408>>Mol Pharmacol. 2004 Jan;65(1):235-43. Quantitative effects on c-Jun Ntuck-2/19/2004
407We've spent most of our time focusing on epothilone D and 17-AAG, but Kosan&tuck-2/9/2004
406Cancer Res. 2004 Jan 1; 64(1): 286-91. Expression of the insulin-like growth scaram(o)uche-1/21/2004
405Quid, Was out last few days. Looks like I missed whatever was up. And since keokalani'nui-1/20/2004
404Another of my stocks (CBST) is behaving kind of the same way today, also on no nBiomaven-1/15/2004
403Wildest, Some folks are evidently thinking it's a priority to step in here.quidditch-1/15/2004
402Update? No. Not a priority for either company it seems.keokalani'nui-1/14/2004
401Probably behind a step here, but has kosn updated investors on the JNJ antibiotirkrw-1/14/2004
400I was doing a google search for 17-AAG and came across this perplexing headline:Biomaven-1/12/2004
399Int J Radiat Biol. 2003 Dec;79(12):973-80. Geldanamycin, an inhibitor of Hsp9scaram(o)uche-1/11/2004
398J Am Chem Soc. 2004 Jan 14;126(1):46-7. Elucidating the Mechanism of cis Doubscaram(o)uche-1/9/2004
397Been wondering the same thing. Of course, if it did stop? Doesn't that meascaram(o)uche-1/9/2004
396Anyone else notice...did it stop? I don't hear or see anything. Can't keokalani'nui-1/9/2004
395Anybody fell like doing an IP search regarding Morphochem and epothilones? Havetuck-1/9/2004
394>>J Neurooncol. 2003 Nov;65(2):99-106. Nanomolar concentrations of epottuck-1/3/2004
393>>Cancer Res. 2003 Dec 1;63(23):8393-9. Combination treatment with 17-Ntuck-12/18/2003
392still rolling in, King Slimeball...... <i>Effective January 1, 2004, apprscaram(o)uche-12/15/2003
391>> Effective January 1, 2004, approximately 1458 shares vest on a monthly scaram(o)uche-12/15/2003
390>>HAYWARD, Calif., Dec. 10 /PRNewswire-FirstCall/ -- Kosan Biosciences Inctuck-12/10/2003
389I did chuckle out loud. Thanks for a good laugh. (eom)mopgcw-12/9/2003
388isn't it pleasant, after we've returned to thin trading, to see that forscaram(o)uche-12/9/2003
387A thorough look at MET, which happens to be a target of Geldanamycin, from Naturtuck-12/8/2003
386>>HAYWARD, Calif., Dec. 8 /PRNewswire-FirstCall/ -- Kosan Biosciences Incotuck-12/8/2003
385Meawhile, KOSN working on its own ways to tweak e. coli for polyketides . . .tuck-12/4/2003
384Reading those abstracts, F3-deH-dEpoB looks like an exciting prospect (but they Biomaven-11/18/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News